Artelo Biosciences

ARTL • NASDAQ • Stock Fundamentals

Artelo Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gregory D. Gorgas, with a market cap of $4.0M.

Market Cap$4.0M

Employees6.0

CEOGregory D. Gorgas

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Artelo Biosciences

Artelo Biosciences (ARTL) has a market capitalization of $4.0M and trades on NASDAQ.

Artelo Biosciences has approximately 6 employees.